OncoPlex Diagnostics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
OncoPlex Diagnostics Inc. - overview
Established
2001
Location
Rockville, MD, US
Primary Industry
Biotechnology
About
OncoPlex Diagnostics Inc. is a biotechnology company that focuses on advanced clinical proteomics, offering training and educational resources for professionals in the fields of oncology and pathology. Founded in 2001 and headquartered in Rockville, US, OncoPlex Diagnostics Inc. specializes in clinical proteomics, providing valuable education and training around protein analysis techniques.
The company raised USD 250,000 in Series A funding in December 2007, with a total amount raised of USD 250,000 and a current valuation of USD 17. 685 mn. OncoPlex Diagnostics Inc. specializes in advanced educational platforms focused on clinical proteomics, utilizing formalin-fixed paraffin-embedded (FFPE) tissue samples.
Their core offerings include training in protein extraction, laser-based microdissection, tissue-based protein microarray fabrication, mass spectrometry sample preparation, and bioinformatics integration with pathology data. These modules are designed to enhance accessibility for students, researchers, and professionals in pathology, oncology, and neuroscience, targeting a global market of small to medium-sized companies and academic institutions. Revenue generation for OncoPlex Diagnostics Inc. is based on subscription access to educational resources and training programs.
Their clients, including academic institutions and research organizations, engage in partnerships allowing them to utilize advanced proteomics training modules on a per-course or subscription basis. Customized pricing structures accommodate diverse client needs, enabling both individuals and organizations to benefit from their offerings. Following recent funding, OncoPlex Diagnostics Inc. aims to expand its educational offerings and explore new markets.
The company plans to develop additional training modules targeting specific techniques in proteomics, with anticipated release dates to be announced. Utilizing the funds acquired from the Series A round in December 2007, the company will support initiatives to extend its reach within the global academic landscape, focusing on partnerships with institutions in North America and Europe.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
www.expressionpathology.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
OncoPlex Diagnostics Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.